Literature DB >> 15603911

Inherited iron loading: genetic testing in diagnosis and management.

Mark Worwood1.   

Abstract

Elucidation of the molecular pathways of iron transport through cells and its control is leading to an understanding of genetic iron loading conditions. The general phenotype of haemochromatosis is iron accumulation in liver parenchymal cells, a raised serum transferrin saturation and ferritin concentration. Four types have been identified: type 1 is the common form and is an autosomal recessive disorder of low penetrance strongly associated with mutations in the HFE gene on chromosome 6(p21.3); type 2 (juvenile haemochromatosis) is autosomal recessive, of high penetrance with causative mutations identified in the HFE2 gene on chromosome 1 (q21) and the HAMP gene on chromosome 19 (q13); type 3 is also autosomal recessive with mutations in the TfR2 gene on chromosome 3 (7q22); type 4 is an autosomal dominant condition with heterozygous mutations in the ferroportin 1 gene. In type 4, iron accumulates in both parenchymal and reticuloendothelial cells and the transferrin saturation may be normal. There are also inherited neurodegenerative conditions associated with iron accumulation. The current research challenges include understanding the central role of the HAMP gene (hepcidin) in controlling iron absorption and the reasons for the variable penetrance in HFE type 1.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15603911     DOI: 10.1016/j.blre.2004.03.003

Source DB:  PubMed          Journal:  Blood Rev        ISSN: 0268-960X            Impact factor:   8.250


  10 in total

1.  Heteroduplex analysis for the three common HFE variants: methodology, reliability and analysis of over 5000 requests for testing.

Authors:  Jeanne Kingston; Derrick Bowen; Marion Sweeney; Susan Lawless; Helen Jackson; Mark Worwood
Journal:  J Clin Pathol       Date:  2006-11-01       Impact factor: 3.411

2.  Clinical utility gene card for: Haemochromatosis [HFE].

Authors:  Manfred Stuhrmann; Heinz Gabriel; Stephen Keeney
Journal:  Eur J Hum Genet       Date:  2010-02-03       Impact factor: 4.246

3.  Targeted screening for genetic haemochromatosis: a combined phenotype/genotype approach.

Authors:  M Bhavnani; D Lloyd; J Marples; K Pendry; M Worwood
Journal:  J Clin Pathol       Date:  2006-05       Impact factor: 3.411

Review 4.  Hereditary hemochromatosis and diabetes mellitus: implications for clinical practice.

Authors:  Kristina M Utzschneider; Kris V Kowdley
Journal:  Nat Rev Endocrinol       Date:  2010-01       Impact factor: 43.330

5.  Unusual presentation of hemochromatosis as isolated metacarpophalangeal joint osteoarthritis: a case report.

Authors:  Sunishka M Wimalawansa; Rannie Alsamkari
Journal:  Hand (N Y)       Date:  2011-05-03

6.  HFE gene mutation, chronic liver disease, and iron overload In Turkey.

Authors:  Oya Yönal; Ozden Hatirnaz; Filiz Akyüz; Ugur Ozbek; Kadir Demir; Sabahattin Kaymakoglu; Atilla Okten; Zeynel Mungan
Journal:  Dig Dis Sci       Date:  2007-04-05       Impact factor: 3.199

7.  Best practice guidelines for the molecular genetic diagnosis of Type 1 (HFE-related) hereditary haemochromatosis.

Authors:  Caitriona King; David E Barton
Journal:  BMC Med Genet       Date:  2006-11-29       Impact factor: 2.103

Review 8.  Safety and efficacy of supplements in pregnancy.

Authors:  Benjamin Brown; Ciara Wright
Journal:  Nutr Rev       Date:  2020-10-01       Impact factor: 7.110

9.  Hemochromatosis (HFE) gene mutations and risk of gastric cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC) study.

Authors:  Antonio Agudo; Catalina Bonet; Núria Sala; Xavier Muñoz; Núria Aranda; Ana Fonseca-Nunes; Françoise Clavel-Chapelon; Marie Christine Boutron-Ruault; Paolo Vineis; Salvatore Panico; Domenico Palli; Rosario Tumino; Sara Grioni; J Ramón Quirós; Esther Molina; Carmen Navarro; Aurelio Barricarte; Saioa Chamosa; Naomi E Allen; Kay-Tee Khaw; H Bas Bueno-de-Mesquita; Peter D Siersema; Mattijs E Numans; Antonia Trichopoulou; Pagona Lagiou; Dimitrios Trichopoulos; Rudof Kaaks; Federico Canzian; Heiner Boeing; Karina Meidtner; Mattias Johansson; Malin Sund; Jonas Manjer; Kim Overvad; Anne Tjonneland; Eiliv Lund; Elisabete Weiderpass; Mazda Jenab; Veronika Fedirko; G Johan A Offerhaus; Elio Riboli; Carlos A González; Paula Jakszyn
Journal:  Carcinogenesis       Date:  2013-02-06       Impact factor: 4.944

10.  Clinical-Pathological Conference Series from the Medical University of Graz : Case No 159: 52-year-old patient with psoriasis and arthralgia of the finger joints.

Authors:  Elisabeth Fabian; Dietmar Schiller; Winfried Graninger; Cord Langner; Johannes Frei; Helmut Schoellnast; Vedat Alibegovic; Rudolf Stauber; Rainer Schoefl; Guenter J Krejs
Journal:  Wien Klin Wochenschr       Date:  2016-06-30       Impact factor: 1.704

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.